BP
SNY icon

Ballentine Partners’s Sanofi SNY Stock Holding History

Ballentine Partners’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$991K Buy
23,224
+10,715
+86% +$479K 0.01% 373
2026
Q1 		$603K Sell
12,509
-343
-3% -$16K 0.01% 466
2025
Q4 		$623K Sell
12,852
-591
-4% -$29.3K 0.01% 435
2025
Q3 		$635K Sell
13,443
-6,281
-32% -$303K 0.01% 426
2025
Q2 		$953K Sell
19,724
-6,339
-24% -$324K 0.01% 332
2025
Q1 		$1.45M Buy
26,063
+10,617
+69% +$575K 0.03% 232
2024
Q4 		$745K Buy
15,446
+2,802
+22% +$142K 0.01% 342
2024
Q3 		$729K Buy
12,644
+2,296
+22% +$124K 0.01% 346
2024
Q2 		$502K Buy
10,348
+2,371
+30% +$114K 0.01% 407
2024
Q1 		$388K Buy
7,977
+539
+7% +$26.3K 0.01% 458
2023
Q4 		$370K Buy
7,438
+402
+6% +$19.7K 0.01% 442
2023
Q3 		$377K Buy
7,036
+600
+9% +$32K 0.01% 379
2023
Q2 		$347K Buy
6,436
+2,696
+72% +$145K 0.01% 412
2023
Q1 		$204K Buy
+3,740
New +$182K 0.01% 521
2022
Q3 		– Sell
-5,322
Closed -$267K – 491
2022
Q2 		$267K Sell
5,322
-3,306
-38% -$175K 0.01% 345
2022
Q1 		$443K Buy
+8,628
New +$446K 0.01% 276
2021
Q4 		– Sell
-5,020
Closed -$242K – 483
2021
Q3 		$242K Sell
5,020
-790
-14% -$40.2K 0.01% 365
2021
Q2 		$306K Sell
5,810
-717
-11% -$37.4K 0.01% 315
2021
Q1 		$323K Buy
6,527
+430
+7% +$20.7K 0.01% 289
2020
Q4 		$296K Sell
6,097
-84
-1% -$4.14K 0.01% 287
2020
Q3 		$310K Buy
6,181
+208
+3% +$10.7K 0.01% 288
2020
Q2 		$305K Sell
5,973
-501
-8% -$24.3K 0.01% 271
2020
Q1 		$283K Buy
6,474
+389
+6% +$18.6K 0.02% 256
2019
Q4 		$305K Buy
6,085
+744
+14% +$34.9K 0.01% 299
2019
Q3 		$247K Buy
5,341
+476
+10% +$20.5K 0.01% 327
2019
Q2 		$210K Buy
4,865
+13
+0.3% +$553 0.01% 362
2019
Q1 		$214K Buy
+4,852
New +$208K 0.01% 302

Other funds holding SNY

DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
FB
Fulton Bank Lancaster, Pennsylvania $3.27B AUM 17.38% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
PCM
Palouse Capital Management Spokane, Washington $160M AUM 36.15% 1-Year Est. Return
AAM
Augustine Asset Management Jacksonville, Florida $494M AUM 76.22% 1-Year Est. Return
BCM
BTC Capital Management Des Moines, Iowa $1.65B AUM 27.85% 1-Year Est. Return

Ballentine Partners's SNY Position: Q2 2026 in Review

Ballentine Partners increased its Sanofi (SNY) stake by 86% in Q2 2026, buying an estimated $479K and bringing the position to 23,224 shares worth $991K. The position accounts for 0.01% of the portfolio, ranked #373.

Ballentine Partners first reported a position in SNY in Q1 2019 and has held it in 27 quarters since. The position peaked at $1.45M in Q1 2025. 94 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Ballentine Partners held 23,224 shares of Sanofi worth $991K as of Q2 2026.
  • Ballentine Partners bought 10,715 Sanofi shares in Q2 2026, an estimated $479K.
  • Sanofi made up 0.01% of Ballentine Partners's portfolio in Q2 2026, its #373 holding.
  • Ballentine Partners first reported a position in Sanofi in Q1 2019 and has held it in 27 quarters since.
  • Ballentine Partners's Sanofi position peaked at $1.45M in Q1 2025.
  • 94 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.